Familial Cancer

, Volume 13, Issue 3, pp 481–488 | Cite as

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors

  • Andreas Dinkel
  • Marielouise Kornmayer
  • Jürgen E. Gschwend
  • Birgitt Marten-Mittag
  • Peter Herschbach
  • Kathleen Herkommer
Original Article

Abstract

Familial clustering is common in prostate cancer (PCa), but the psychosocial consequences of being a PCa patient in an affected family are not well understood. This study investigated the effects of family history of PCa on psychosocial distress and perceived psychosocial treatment need. Data were gathered within the German national research project “Familial Prostate Cancer”. 4.123 PCa survivors who had undergone prostatectomy at least 4 years ago received a questionnaire set. 3.623 of the respondents [68.3 % sporadic, sporadic prostate cancer (SPCa); 31.7 % familial, familial prosate cancer (FPCa)] filled in measures of cancer-specific distress (QSC-R10), depression (PHQ-2), and anxiety (GAD-2). Perceived psychosocial treatment need was assessed using a single item. The prevalence of psychosocial distress did not differ between SPCa and FPCa survivors (cancer-specific distress: 16.2 vs. 16.7 %; depression: 5.8 vs. 6.4 %; anxiety: 6.6 vs. 5.8 %; ps ≥ .397). Similarly, psychosocial treatment need did not differ between SPCa (11.8 %) and FPCa (13.1 %) cases (p = .303). However, family history moderated the effect of cancer-specific distress on treatment need (OR 2.67, 95 % CI 1.43–4.96, p = .002). Exploratory analyses for the hereditary subtype (HPCa) revealed that cancer-specific distress was lower in HPCa survivors who had only daughters compared to survivors without any children or with at least one son. No such effect was observed in SPCa survivors (p = .040). PCa survivors with a positive family history do not experience increased psychosocial distress. Nonetheless, family history may exert subtle effects that deserve further research.

Keywords

Familial cancer Family history Hereditary cancer Prostate cancer Psychosocial distress 

Supplementary material

10689_2014_9715_MOESM1_ESM.docx (17 kb)
(DOCX 38 kb)

References

  1. 1.
    Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30PubMedCrossRefGoogle Scholar
  2. 2.
    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403PubMedCrossRefGoogle Scholar
  3. 3.
    Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (ed): Krebs in Deutschland 2007/2008 [Cancer in Germany 2007/2008]. Berlin, 2012Google Scholar
  4. 4.
    Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRefGoogle Scholar
  5. 5.
    Bruner DW, Moore D, Parlanti D et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRefGoogle Scholar
  6. 6.
    Brandt A, Bermejo JL, Sundquist J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRefGoogle Scholar
  7. 7.
    Hemminki K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143–148PubMedCrossRefGoogle Scholar
  8. 8.
    Hemminki K, Sundquist J, Bermejo JL (2008) How common is familial cancer? Ann Oncol 19:163–167PubMedCrossRefGoogle Scholar
  9. 9.
    Herkommer K, Schmidt C, Gschwend JE (2011) Zehn Jahre nationales Forschungsprojekt “Familiäres Prostatakarzinom”. Probleme der Identifikation von Risikofamilien [Ten years national research project “Familial Prostate Cancer”. Problems in identifying risk families]. Urologe 50:813–820PubMedCrossRefGoogle Scholar
  10. 10.
    Siddiqui SA, Sengupta S, Slezak JM et al (2006) Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol 176:1118–1121PubMedCrossRefGoogle Scholar
  11. 11.
    Colloca G, Venturino A (2011) The evolving role of familial history for prostate cancer. Acta Oncol 50:14–24PubMedCrossRefGoogle Scholar
  12. 12.
    Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391PubMedCrossRefGoogle Scholar
  13. 13.
    Ewing CM, Ray AM, Lange EM et al (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366:141–149PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29:3659–3668PubMedCrossRefGoogle Scholar
  15. 15.
    Carter B, Bova G, Beaty Y et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802PubMedGoogle Scholar
  16. 16.
    Kupelian PA, Reddy CA, Reuther AM et al (2006) Aggressiveness of familial prostate cancer. J Clin Oncol 24:3445–3450PubMedCrossRefGoogle Scholar
  17. 17.
    Lee KL, Marotte JB, Ferrari MK et al (2005) Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 65:311–315PubMedCrossRefGoogle Scholar
  18. 18.
    Roehl KA, Loeb S, Antenor JAV et al (2006) Characteristics of patients with familial versus sporadic prostate cancer. J Urol 176:2438–2442PubMedCrossRefGoogle Scholar
  19. 19.
    Rouprêt M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67:1028–1032PubMedCrossRefGoogle Scholar
  20. 20.
    Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312–1317PubMedCrossRefGoogle Scholar
  21. 21.
    Jacobson PB, Lamonde LA, Honour M et al (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behaviour. Psychooncology 13:80–85CrossRefGoogle Scholar
  22. 22.
    McDowell ME, Occhipinti S, Gardiner RA et al (2013) Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psychooncology 22:2496–2504PubMedCrossRefGoogle Scholar
  23. 23.
    Meiser B, Cowan R, Costello A et al (2007) Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men’s screening uptake. Urology 70:738–742PubMedCrossRefGoogle Scholar
  24. 24.
    Cormier L, Valéri A, Azzouzi R et al (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51:276–285PubMedCrossRefGoogle Scholar
  25. 25.
    Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235–241PubMedCrossRefGoogle Scholar
  26. 26.
    Matthew AG, Paradiso C, Currie KL et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85:251–257PubMedCrossRefGoogle Scholar
  27. 27.
    Tavlarides AM, Ames SC, Diehl NN et al (2013) Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology 22:1328–1335PubMedCrossRefGoogle Scholar
  28. 28.
    Paiss T, Herkommer K, Bock B et al (2003) Association between the clinical presentation and epiemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615–621PubMedCrossRefGoogle Scholar
  29. 29.
    Book K, Marten-Mittag B, Henrich G et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10) in a German sample. Psychooncology 20:287–293PubMedCrossRefGoogle Scholar
  30. 30.
    Herschbach P, Marten-Mittag B, Henrich G (2003) Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23) [Revision and psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R23)]. Z Med Psychol 12:69–76Google Scholar
  31. 31.
    Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer specific distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 282:1737–1744PubMedCrossRefGoogle Scholar
  33. 33.
    Gräfe K, Zipfel S, Herzog W et al (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der deutschen Validierungsstudie [Screening for psychiatric disorders with the Patient Health Questionnaire: results from the German validation study]. Diagnostica 50:171–181CrossRefGoogle Scholar
  34. 34.
    Löwe B, Wahl I, Rose M et al (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRefGoogle Scholar
  35. 35.
    Dinkel A, Berth H, Tchitchekian G et al (2010) Bedürfnis nach psychosozialer Beratung und Inanspruchnahme psychosozialer Hilfen bei Krebspatienten [Perceived need for psychosocial support and utilization of support services in cancer patients]. In: Berth H (ed) Psychologie und Medizin. Lengerich, Pabst, pp 107–117Google Scholar
  36. 36.
    Geirdal AØ, Dahl AA (2008) The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. J Genet Counsel 17:384–393CrossRefGoogle Scholar
  37. 37.
    Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28:510–518PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Gopie JP, Vasen HFA, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Crit Rev Oncol Hematol 83:329–340PubMedCrossRefGoogle Scholar
  39. 39.
    Rabkin C, Rogers ML, Pinto BM et al (2007) Effect of personal cancer history and family cancer history on levels of psychological distress. Soc Sci Med 64:411–416CrossRefGoogle Scholar
  40. 40.
    Kowalkowski MA, Hart SL, Du XL et al (2012) Cancer perceptions: implications from the 2007 Health Information National Trends Survey. J Cancer Surviv 6:287–295PubMedCrossRefGoogle Scholar
  41. 41.
    Mols F, van de Poll-Franse LV, Vingerhoets JJM et al (2006) Long-term quality of life among Dutch prostate cancer survivors. Results of a population-based study. Cancer 107:2186–2196PubMedCrossRefGoogle Scholar
  42. 42.
    Boorjian SA, Eastham JA, Graefen M et al (2012) A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 61:664–675PubMedCrossRefGoogle Scholar
  43. 43.
    Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259–1265PubMedCrossRefGoogle Scholar
  44. 44.
    Hruza B, Bermejo JL, Flinspach B et al (2013) Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int 111:271–280PubMedCrossRefGoogle Scholar
  45. 45.
    Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at high risk for prostate carcinoma. Cancer 176:765–774CrossRefGoogle Scholar
  47. 47.
    Wallner LP, Sarma AV, Lieber MM et al (2008) Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County Study. Cancer Epidemiol Biomarkers Prev 17:3588–3592PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Patenaude AF, DeMarco TA, Peshkin BN et al (2013) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Counsel 22:303–314CrossRefGoogle Scholar
  49. 49.
    Esplen MJ, Madlensky L, Aronson M et al (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRefGoogle Scholar
  50. 50.
    Atkinson TM, Noce NS, Hay J et al (2013) Ilness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol 20:675–679PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Stinesen-Kollberg K, Thorsteinsdottir T, Wilderäng U et al (2013) Worry about one’s own children, psychological well-being, and interest in psychosocial intervention. Psychooncology 22:2117–2123PubMedCrossRefGoogle Scholar
  52. 52.
    Eisinger F, Bouhnik AD, Malavolti L et al (2011) Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 10:147–155PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Andreas Dinkel
    • 1
  • Marielouise Kornmayer
    • 2
  • Jürgen E. Gschwend
    • 2
  • Birgitt Marten-Mittag
    • 1
  • Peter Herschbach
    • 1
    • 3
  • Kathleen Herkommer
    • 2
  1. 1.Division of Psychosocial Oncology, Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  2. 2.Department of Urology, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  3. 3.Roman-Herzog-Comprehensive Cancer Center (RHCCC), Klinikum rechts der IsarTechnische Universität MünchenMunichGermany

Personalised recommendations